We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CS
4076
DELISTED
Credit Suisse Group
CS
$9K ﹤0.01%
870
-5,130
-86% -$46.1K
AGRX
4077
DELISTED
Agile Therapeutics
AGRX
$9K ﹤0.01%
+2
New +$10.4K
DWPP
4078
DELISTED
First Trust Dorsey Wright People's Portfolio ETF
DWPP
$9K ﹤0.01%
365
+276
+310% +$7K
FMTX
4079
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$9K ﹤0.01%
+196
New +$8.5K
BBQ
4080
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$9K ﹤0.01%
+2,701
New +$7.3K
VOLT
4081
DELISTED
Volt Information Sciences, Inc.
VOLT
$9K ﹤0.01%
+7,015
New +$6.53K
ZSAN
4082
DELISTED
Zosano Pharma Corporation
ZSAN
$9K ﹤0.01%
+317
New +$8.95K
PS
4083
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$9K ﹤0.01%
508
-287
-36% -$4.86K
PACQU
4084
DELISTED
Pure Acquisition Corp. Unit
PACQU
$9K ﹤0.01%
888
CVIA
4085
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$9K ﹤0.01%
18,676
+18,465
+8,751% +$10.1K
WSTL
4086
DELISTED
Westell Technologies Inc
WSTL
$9K ﹤0.01%
+11,329
New +$9.1K
PKO
4087
DELISTED
Pimco Income Opportunity Fund
PKO
$9K ﹤0.01%
+419
New +$8.89K
LBTYB
4088
DELISTED
Liberty Global plc Class B
LBTYB
$9K ﹤0.01%
+394
New +$9K
ACET icon
4089
Adicet Bio
ACET
$75.9M
$8K ﹤0.01%
+34
New +$6.68K
ANGI icon
4090
Angi Inc
ANGI
$186M
$8K ﹤0.01%
+64
New +$5.83K
ARCO icon
4091
Arcos Dorados Holdings
ARCO
$1.7B
$8K ﹤0.01%
+1,949
New +$7.27K
ARKK icon
4092
ARK Innovation ETF
ARKK
$6.37B
$8K ﹤0.01%
119
-39,201
-100% -$2.29M
ARMP icon
4093
Armata Pharmaceuticals
ARMP
$169M
$8K ﹤0.01%
+2,097
New +$7.27K
BTZ icon
4094
BlackRock Credit Allocation Income Trust
BTZ
$958M
$8K ﹤0.01%
+600
New +$7.91K
COGT icon
4095
Cogent Biosciences
COGT
$7.1B
$8K ﹤0.01%
+4,097
New +$7.6K
CRH icon
4096
CRH
CRH
$66.9B
$8K ﹤0.01%
221
-1,346
-86% -$41.5K
DRD
4097
DRDGold
DRD
$2.05B
$8K ﹤0.01%
495
-18
-4% -$178
DT icon
4098
Dynatrace
DT
$14.6B
$8K ﹤0.01%
+204
New +$6.71K
ETV
4099
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.77B
$8K ﹤0.01%
+600
New +$8.09K
EWL icon
4100
iShares MSCI Switzerland ETF
EWL
$2.24B
$8K ﹤0.01%
207
-1,161
-85% -$43.6K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.